Cargando…

Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients

Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contain...

Descripción completa

Detalles Bibliográficos
Autores principales: Pigliasco, Federica, Malaca, Sara, Lo Faro, Alfredo Fabrizio, Tini, Anastasio, Cangemi, Giuliana, Cafaro, Alessia, Barco, Sebastiano, Riva, Antonella, Pisati, Angelica, Amadori, Elisabetta, Striano, Pasquale, Tagliabracci, Adriano, Huestis, Marilyn Ann, Busardò, Francesco Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637868/
https://www.ncbi.nlm.nih.gov/pubmed/36353497
http://dx.doi.org/10.3389/fphar.2022.1038754
_version_ 1784825278422319104
author Pigliasco, Federica
Malaca, Sara
Lo Faro, Alfredo Fabrizio
Tini, Anastasio
Cangemi, Giuliana
Cafaro, Alessia
Barco, Sebastiano
Riva, Antonella
Pisati, Angelica
Amadori, Elisabetta
Striano, Pasquale
Tagliabracci, Adriano
Huestis, Marilyn Ann
Busardò, Francesco Paolo
author_facet Pigliasco, Federica
Malaca, Sara
Lo Faro, Alfredo Fabrizio
Tini, Anastasio
Cangemi, Giuliana
Cafaro, Alessia
Barco, Sebastiano
Riva, Antonella
Pisati, Angelica
Amadori, Elisabetta
Striano, Pasquale
Tagliabracci, Adriano
Huestis, Marilyn Ann
Busardò, Francesco Paolo
author_sort Pigliasco, Federica
collection PubMed
description Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains THC and CBD in different ratios, along with minor phytocannabinoids, terpenes, flavonoids and other chemicals. A volumetric absorptive microsampling (VAMS) method combined with ultra-high-performance liquid chromatography coupled with mass spectrometry in tandem for quantification of CBD, THC and their respective metabolites: cannabidiol-7-oic acid (7-COOH-CBD); 7-hydroxy-cannabidiol (7-OH-CBD); 6-alpha-hydroxy-cannabidiol (6-α-OH-CBD); and 6-beta-hydroxycannabidiol (6-β-OH-CBD); 11- Hydroxy-Δ(9)-tetrahydrocannabinol (11-OH-THC) and 11-Nor-9-carboxy-Δ(9)-tetrahydrocannabinol (THCCOOH). After overnight enzymatic glucuronide hydrolysis at 37°C, samples underwent acidic along with basic liquid-liquid extraction with hexane: ethyl acetate (9:1, v/v). Chromatographic separation was carried out on a C18 column, with the mass spectrometer operated in multiple reaction monitoring mode and negative electrospray ionization. Seven patients with intractable epilepsy were dosed with various CBD-containing formulations and blood collected just before their daily morning administration. The method was validated following international guidelines in toxicology. Linear ranges were (ng/ml) 0.5–25 THC, 11-OH-THC, THCCOOH, 6-α-OH-CBD and 6-β-OH-CBD; 10–500 CBD and 7-OH-CBD; and 20–5000 7-COOH-CBD. 7-COOH-CBD was present in the highest concentrations, followed by 7-OH-CBD and CBD. This analytical method is useful for investigating CBD, THC and their major metabolites in epilepsy patients treated with CBD preparations employing a minimally invasive microsampling technique requiring only 30 µL blood.
format Online
Article
Text
id pubmed-9637868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96378682022-11-08 Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients Pigliasco, Federica Malaca, Sara Lo Faro, Alfredo Fabrizio Tini, Anastasio Cangemi, Giuliana Cafaro, Alessia Barco, Sebastiano Riva, Antonella Pisati, Angelica Amadori, Elisabetta Striano, Pasquale Tagliabracci, Adriano Huestis, Marilyn Ann Busardò, Francesco Paolo Front Pharmacol Pharmacology Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ(9)-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains THC and CBD in different ratios, along with minor phytocannabinoids, terpenes, flavonoids and other chemicals. A volumetric absorptive microsampling (VAMS) method combined with ultra-high-performance liquid chromatography coupled with mass spectrometry in tandem for quantification of CBD, THC and their respective metabolites: cannabidiol-7-oic acid (7-COOH-CBD); 7-hydroxy-cannabidiol (7-OH-CBD); 6-alpha-hydroxy-cannabidiol (6-α-OH-CBD); and 6-beta-hydroxycannabidiol (6-β-OH-CBD); 11- Hydroxy-Δ(9)-tetrahydrocannabinol (11-OH-THC) and 11-Nor-9-carboxy-Δ(9)-tetrahydrocannabinol (THCCOOH). After overnight enzymatic glucuronide hydrolysis at 37°C, samples underwent acidic along with basic liquid-liquid extraction with hexane: ethyl acetate (9:1, v/v). Chromatographic separation was carried out on a C18 column, with the mass spectrometer operated in multiple reaction monitoring mode and negative electrospray ionization. Seven patients with intractable epilepsy were dosed with various CBD-containing formulations and blood collected just before their daily morning administration. The method was validated following international guidelines in toxicology. Linear ranges were (ng/ml) 0.5–25 THC, 11-OH-THC, THCCOOH, 6-α-OH-CBD and 6-β-OH-CBD; 10–500 CBD and 7-OH-CBD; and 20–5000 7-COOH-CBD. 7-COOH-CBD was present in the highest concentrations, followed by 7-OH-CBD and CBD. This analytical method is useful for investigating CBD, THC and their major metabolites in epilepsy patients treated with CBD preparations employing a minimally invasive microsampling technique requiring only 30 µL blood. Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9637868/ /pubmed/36353497 http://dx.doi.org/10.3389/fphar.2022.1038754 Text en Copyright © 2022 Pigliasco, Malaca, Lo Faro, Tini, Cangemi, Cafaro, Barco, Riva, Pisati, Amadori, Striano, Tagliabracci, Huestis and Busardò. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pigliasco, Federica
Malaca, Sara
Lo Faro, Alfredo Fabrizio
Tini, Anastasio
Cangemi, Giuliana
Cafaro, Alessia
Barco, Sebastiano
Riva, Antonella
Pisati, Angelica
Amadori, Elisabetta
Striano, Pasquale
Tagliabracci, Adriano
Huestis, Marilyn Ann
Busardò, Francesco Paolo
Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title_full Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title_fullStr Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title_full_unstemmed Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title_short Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
title_sort cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and lc-ms/ms following controlled administration in epilepsy patients
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637868/
https://www.ncbi.nlm.nih.gov/pubmed/36353497
http://dx.doi.org/10.3389/fphar.2022.1038754
work_keys_str_mv AT pigliascofederica cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT malacasara cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT lofaroalfredofabrizio cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT tinianastasio cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT cangemigiuliana cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT cafaroalessia cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT barcosebastiano cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT rivaantonella cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT pisatiangelica cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT amadorielisabetta cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT strianopasquale cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT tagliabracciadriano cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT huestismarilynann cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients
AT busardofrancescopaolo cannabidiol9tetrahydrocannabinolandmetabolitesinhumanbloodbyvolumetricabsorptivemicrosamplingandlcmsmsfollowingcontrolledadministrationinepilepsypatients